Please use this identifier to cite or link to this item:
http://dspace.bits-pilani.ac.in:8080/jspui/xmlui/handle/123456789/13482| Title: | Simultaneous inhibition of neprilysin and activation of ACE2 prevented diabetic cardiomyopathy |
| Authors: | Gaikwad, Anil Bhanudas |
| Keywords: | Pharmacy Cardiomyopathy Neprilysin inhibitors (NEPi) Angiotensin-converting enzyme (ACE2) |
| Issue Date: | Oct-2019 |
| Publisher: | Elsevier |
| Abstract: | Neprilysin inhibitors (NEPi) are assisting the renin-angiotensin system (RAS) inhibitors in halting diabetic cardiomyopathy (DCM). Away from conventional tactic, a recent report revealed the renoprotective potential of NEPi and angiotensin-converting enzyme (ACE2) activator combination therapy against diabetic nephropathy. However, this combination so far not evaluated against DCM, thus the present investigation aiming the same. |
| URI: | https://www.sciencedirect.com/science/article/abs/pii/S1734114019301185 http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13482 |
| Appears in Collections: | Department of Pharmacy |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.